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Key points summary 
 Many studies have previously suggested the existence of stress hormone 
receptors on the cell membrane of many cell types including skeletal muscle 
fibres. However, the exact localisation of these receptors and how they signal 
to the rest of the cell is poorly understood.  
 In this study, we investigated the localisation and the mechanism(s) 
underlying the physiological functions of these receptors in mouse skeletal 
muscle cells. 
 We found that the receptors were present throughout muscle development 
and that, in adult muscle fibres, they were localised in the extracellular matrix, 
satellite cells (muscle stem cells) and close to mitochondria.  
 We also found that they signalled to the rest of the cell by activating enzymes 
called mitogen-activated protein kinases. 
 From these results we suggest that, at physiological concentrations, stress 
hormones may be important in skeletal muscle differentiation, repair and 
regeneration. 
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Abstract 
A number of studies have previously proposed the existence of glucocorticoid 
receptors on the plasma membrane of many cell types including skeletal muscle 
fibres. However, their exact localisation and the cellular signalling pathway(s) they 
utilise to communicate with the rest of the cell are still poorly understood. In this 
study, we investigated the localisation and the mechanism(s) underlying the non-
genomic physiological functions of these receptors in mouse skeletal muscle cells. 
The results show that the receptors were localised in the cytoplasm in myoblasts, in 
the nucleus in myotubes and in the extracellular matrix, in satellite cells and in the 
proximity of mitochondria in adult muscle fibres. Also, they bound laminin in a 
glucocorticoid-dependent manner. Treating small skeletal muscle fibre bundles with 
the synthetic glucocorticoid, beclomethasone dipropionate, increased the 
phosphorylation (=activation) of extracellular-signal regulated kinase 1&2, c-Jun N-
terminal kinase and p38 mitogen-activated protein kinase.  This occurred within 5min 
and depended on the fibre-type and the duration of the treatment. It was also 
abolished by the glucocorticoid receptor inhibitor, mifepristone, and a monoclonal 
antibody against the receptor. From these results we conclude that the non-
genomic/non-canonical physiological functions of glucocorticoids, in adult skeletal 
muscle fibres are mediated by a glucocorticoid receptor localised in the extracellular 
matrix, in satellite cells and close to mitochondria and involve activation of the MAPK 
pathway.  
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Abbreviations list 
BDP, Becomethasone dipropionate; ERK1&2, Extracellular-signal regulated kinase 
1&2; FAK, Focal adhesion kinase; FAKi-14, Focal adhesion kinase inhibitor 14; GC, 
Glucocorticoid; GR, Glucocorticoid receptor; cGR, Cytosolic glucocorticoid receptor; 
mGR, Membrane glucocorticoid receptor; JNK, c-Jun N-terminal kinase; MAPK, 
Mitogen-activated protein kinase; mTOR, Mammalian target of rapamycin; p38 
MAPK, p38 mitogen-activated protein kinase. 
Introduction 
Glucocorticoids (GCs, steroids) are the main stress hormones in the body. They are 
synthesised from cholesterol and released from cells in the zona fasciculata of the 
adrenal cortex. In healthy individuals, they are released in short irregular bursts that 
peak ~2hrs before the start of the day and whose plasma concentration rarely 
exceeds 250nM except during stress when it can be as high as 700nM (Krieger et al, 
1971). GCs are essential for life and affect most tissues in the body including 
skeletal muscle. Indeed, skeletal muscle plays a key role in the stress response 
because it enables individuals to evade or to fight the stressor. Despite this, little is 
known about the physiological functions of GCs in skeletal muscle especially at the 
low concentrations normally found in plasma. Instead, what has been extensively 
studied and reported are the effects of treating laboratory animals, for long periods, 
with high doses of synthetic GCs (especially dexamethasone) on skeletal muscle 
function (Nava et al, 1996; van Balkom et al, 1997; Ma et al, 2003) and protein 
metabolism (Goldberg, 1969; Rannels & Jefferson, 1980; Wing & Goldberg, 1993). A 
lot is also known about the effects of lack of (Addison’s disease) and excess of 
(Cushing syndrome) GCs on skeletal muscle mass and function. 
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GCs exert most of their physiological and pharmacological effects through an 
intracellular glucocorticoid receptor (GR, GCR, NR3C1). The GR belongs to the 
super family of ligand-activated nuclear transcription factors that include the steroid, 
thyroid and retinoic acid receptors (Kadmiel & Cidlowski, 2013).  It is coded for by a 
single gene (the NR3C1 gene) that is spliced into two main isoforms, GRα (which is 
the active form) and GRβ (which is inactive and resides in the nucleus where it acts 
as a dominant negative inhibitor of GRα) (Kadmiel & Cidlowski, 2013). GRα 
(henceforth referred to as GR) is expressed in most cells, including muscle fibres 
(=cells), where the inactive receptor is thought to reside in the cytosol (hence 
cytosolic GR, cGR). In this state, the receptor is maintained in its high affinity 
conformation and is protected from inactivation by chaperone molecules such as 
heat shock proteins (HSPs) e.g. HSP 90 and immunophilins e.g. FK506 binding 
protein (FKBP) 51 (Pratt and Toft, 2003). However, in a recent study we showed 
that, in adult mammalian skeletal muscle fibres, GRs were localised close to the 
surface of muscle fibres where they co-localised with laminin. We were also able to 
inhibit their effects on force using a monoclonal antibody against the receptor 
suggesting that they were easily accessible from the cell surface (Perez et al. 2013).  
Although a number of studies have previously alluded to the existence of membrane 
glucocorticoid receptors (mGRs) in other cell types including human lymphoma cells 
(Gametchu, 1993), peripheral blood mononuclear cells (Bartholome et al. 2004) and 
neuronal cells (Orchinik et al. 1991) their precise location is still unknown. It is also 
uncertain whether in skeletal muscle the GRs are localised close to the cell surface 
throughout myogenesis or just in adult muscle fibres. 
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In addition to their genomic actions, GCs also exert actions that occur within minutes 
and are relatively insensitive to inhibitors of transcription and translation (Stahn and 
Buttgereit 2008; Perez et al. 2013). These non-canonical/non-genomic actions have 
been described in many cell types including HeLa cells (Bruna et al, 2003; Lasa et 
al, 2002); guinea pig neurones (Hua and Chen, 1989), human endometrial cells 
(Hafezi-Moghadam et al, 2002), human adenocarcinoma cells (Croxtall et al, 2000), 
rat thymocytes (Buttgeriet et al, 1997), airway vasculature (Alangari, 2010) and 
skeletal muscle (Perez et al, 2013). However, the cellular signal transduction events 
mediating them are still poorly understood. The receptor/mechanism underlying their 
actions is also controversial. 
The primary aims of this study were two fold; (1) to investigate the localisation and 
physiological functions of the GR in mouse skeletal muscle cells and (2) to determine 
the cellular signal transduction events mediating their non-genomic physiological 
actions in adult mammalian skeletal muscle fibres. 
Materials and methods 
Small intact skeletal muscle fibre bundles. The experiments reported here were 
performed at room temperature (~20°C) using small skeletal muscle fibre bundles 
(~540±26µm in diameter) isolated from the extensor digitorum longus (EDL; a fast-
twitch) or the soleus (slow-twitch) of adult male C57BL/6 mice. The mice were killed 
according to UK legislation (for a summary of the legislation see Drummond 2009) 
and all the experiments conformed to the University of East Anglia animal welfare 
committee guidelines. Throughout the experiments, the muscles and muscle fibre 
bundles were bathed in mammalian Ringer’s solution with the following composition 
(in mM); 109 NaCl, 5 KCl, 1 MgCl2, 4 CaCl2, 24 NaHCO3, 1 NaHPO4, 10 sodium 
pyruvate plus 400mg l-1 foetal bovine serum (FBS). The pH of the Ringer’s solution 
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was maintained at ~7.42 by continuously bubbling it with 95% O2 and 5% CO2. To 
avoid any confounding influence of the GCs present in the FBS, serum from the 
same batch was used in all the experiments. 
Cell culture. C2C12 cells  were grown on cover slips in growth media (Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with 1% L-glutamine plus10% FBS 
and 1% penicillin and streptomycin (all purchased from Sigma Aldrich, Poole, UK) for 
3-4 days or until 90% confluence. Once 90% confluent, they were induced to 
differentiate by replacing the growth media with differentiation media i.e. growth 
media containing 2% horse serum instead of FBS. At the end of the experiment the 
cells were washed in phosphate buffered saline (PBS), air dried and permeabilised 
for 15min using Tris buffered saline with Tween® 20 (TBST). They were blocked for 
non-specific antibody binding for 10min using 1% BSA PBS. Finally, they were 
immunoblotted for the expression of the GR, laminin and double stranded DNA as 
described below.Determination of the effects of beclomethasone 
(Beclometasone) dipropionate (BDP) on the MAPK pathway. This experiment 
was performed as previously described in Hamdi & Mutungi (2010 and 2011). Briefly, 
the muscle fibre bundles were mounted horizontally between two stainless steel 
hooks in a Perspex muscle chamber (total volume ~40ml) with a glass bottom. Half 
of the bundles (controls) were treated for 5, 10, 30 and 60 minutes with the standard 
Ringer’s solution plus 34nM ethanol (the vehicle used to dissolve BDP). The other 
half (experimental) was treated for the same period of time with the Ringer’s solution 
containing 250nM BDP. At the end of the experiment, the fibre bundles were snap-
frozen in liquid nitrogen and cytosolic proteins were extracted using NP40 lysis 
buffer. The proteins were immunoblotted for the activation/phosphorylation of c-Jun 
N-terminal kinase (JNK; also known as stress-activated protein kinase/SAPK); 
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extracellular signal-regulated kinase (ERK) 1&2) and p38 mitogen-activated protein 
kinase (MAPK) as described below. 
Determination of the receptor/mechanism mediating the effects of BDP in 
mammalian skeletal muscle fibres. To determine whether the effects of BDP on 
the MAPK pathway were mediated through the GR and whether the receptor was 
localised close to the fibre surface, another set of fast-twitch and slow-twitch bundles 
was divided into three groups. Group 1 (controls) were treated with the standard 
Ringer’s solution plus the vehicle used to dissolve the GC (ethanol) and mifepristone 
(DMSO). Group 2 was pre-incubated for 10min in Ringer’s solution containing 10µM 
mifepristone (RU486; a GR inhibitor) (Sigma-Aldrich, Gillingham, Dorset, UK); 
whereas, Group 3 was pre-incubated for the same period in a 1:5000 dilution of a 
monoclonal anti-GR (ab109022, Abcam, Cambridge, UK). The fibres in Group 2 
were then treated for a further 30 minutes with the Ringer’s solution containing 10µM 
mifepristone alone or mifepristone plus 250nM BDP; whereas, those in Group 3 were 
treated  for 5 minutes with the Ringer’s solution plus 1:5000 dilution of the anti-GR 
alone or 1:5000 dilution of the anti-GR plus 250nM BDP. To determine whether the 
effects of BDP were mediated via focal adhesion kinase (FAK), another set of fibres 
was pre-treated with 10μM FAK inhibitor (FAKi) 14 (Abcam, Cambridge, UK). They 
were then incubated for a further 10min in Ringer’s solution containing the inhibitor 
alone or the inhibitor plus 250nM BDP. At the end of these experiments, the fibre 
bundles were frozen and cytosolic proteins were extracted using NP40 lysis buffer. 
They were then immunoblotted for the activation of ERK 1&2, JNK and p38 MAPK 
as described below. 
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Immunoblotting. To determine the effects of BDP on the activation/phosphorylation 
of ERK 1&2, JNK and p38 MAPK equal amounts of the proteins were immunoblotted 
as previously described in Perez et al. (2013). Briefly, 10μg of the proteins were 
separated by standard gel-electrophoresis and transferred onto nitrocellulose 
membranes. The membranes were blocked for non-specific anti-body binding using 
5% milk. They were then immunoblotted for the expression of pERK 1&2, pJNK and 
pp38 MAPK using a 1:500 dilution of rabbit monoclonal antibodies (4377, 4671 and 
9215, respectively) from Cell Signalling Technologies® (New England Biolabs, Herts, 
UK) and the expression of the GR using a 1:500 dilution of the monoclonal anti-GR 
from Abcam used in the experiment above (ab109022; Cambridge, UK). Finally, they 
were visualized using SuperSignal WestPico chemiluminescence substrate (Perbio 
Science UK Ltd, Cramlington, Northumberland) and exposure to film. 
The following day, the membranes were stripped and re-probed with a pan-actin 
antibody (ab3280, Abcam, Cambridge, UK) to check for loading. In some 
experiments, the fibre bundles were fibre typed using monoclonal antibodies against 
fast and slow MyHCs (Sigma-Aldrich, Gillingham, Dorset, UK). All the blots were run 
in duplicate and each experiment was repeated at least twice. 
Immunocytochemistry. The expression and localisation of the GR in myoblasts, 
myotubes and adult mammalian skeletal muscles fibre bundles was determined as 
previously described in Perez et al. (2013). Briefly, the EDL and soleus muscles 
isolated from adult male C57BL/6 mice were mounted perpendicularly on cryostat 
chucks using tissue Tek® OCT™ compound (Sakura Finetek UK Ltd, Berkshire, UK). 
They were snap frozen in liquid nitrogen cooled isopentane and 10µm thick serial 
sections were cut. Two of the sections and the two cover slips of myoblasts and 
myotubes (grown as described above) were blocked for non-specific antibody 
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labelling using 1% bovine serum albumin (BSA) dissolved in PBS. They were 
incubated at room temperature, for at least 1hr, with a 1:200 dilution of a monoclonal 
rat anti-laminin (MAB1905, Millipore Corporation, Billerica, MA, USA) and a 1:100 
dilution of the monoclonal rabbit anti-GCR from Abcam (ab109022; Cambridge, UK). 
They were then washed five times in PBS and incubated in 1:500 dilution of species 
specific secondary antibodies conjugated to alexa fluorophores for 1hr. Finally, 
Hoechest 33342 (a double stranded DNA staining dye; Life Technologies, Paisley, 
UK) was added 5 minutes before the end of this incubation. Two more sections and 
cover slips (controls) were incubated with the primary or the secondary antibodies 
only. At the end of the incubation period, the sections and cover slips were washed 4 
times in TBST, dried and mounted for viewing. Finally, they were visualised and 
photographed using an Axioplan 2 Imaging® microscope and AxioVison Release® 
4.8 software (Carl Zeiss, Cambridge, UK). Like all the immunoblotting experiments, 
the immunocytohistochemistry was performed in duplicate and each experiment was 
repeated at least twice. 
Pull down assay. To determine whether the GR was able to bind laminin, a 
modification of the pull-down assay described in De Beer et al. (1981) was used.  
Briefly, 250µg recombinant human merosin (laminin 2; laminin 211; Millipore (UK) 
limited, Hertfordshire, UK) the main laminin in skeletal muscle or 100µg recombinant 
mouse integrin α7β1 (the main integrins in mammalian skeletal muscle; R&D 
Systems, Abingdon, Oxford, UK) were coupled to cyanogen bromide (CNBr)-
activated sepharose beads (Sigma-Aldrich, Gillingham, Dorset, UK), according to the 
manufacturer’s instructions. The excess ligand was washed off with coupling buffer 
and all the unbound active groups were blocked using 0.2M glycine. 300µl of slow-
twitch muscle lysate was added to the beads alone, the beads plus laminin or the 
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beads plus integrin and left over night at 4°C on a rotator. Slow-twitch muscle lysate 
was used because slow muscle expresses 4-5 times more GR than fast-twitch 
muscle (Perez et al, 2013). The following morning, the beads were washed two 
times with TBST and once in PBS. They were then mixed with 30-40µl elution buffer 
(Laemmli sample loading buffer) and left on a rotator for 1h. Finally, they were 
centrifuged at 2000g for 20sec and the supernatant was collected. 10µl of each 
supernatant was separated using standard gel-electrophoresis, transferred on to 
nitrocellulose membrane and finally immunoblotted for the GR using 1:500 dilution of 
the rabbit monoclonal anti-GR antibody from Abcam as described above. 
Immunofluorescence confocal microscopy (CM). Soleus muscles from 6 month 
old C57BL/6 mice were fixed in 2% paraformaldehyde in phosphate buffered saline 
(PBS) for 2 hours at room temperature.  Small bundles were washed twice with PBS 
and blocked for 1 hour in PBS containing 1% BSA, 10% goat serum and 0.5% 
TritonX-100 (added to permeabilise the membrane). They were incubated overnight 
at 4°C in primary antibody and the following morning they were washed three times 
in PBS. They were incubated with the secondary antibody for one hour at room 
temperature before being mounted on coverslips with anti-bleach media (Slowfade 
Gold antifade reagent, Invitrogen).  Primary antibodies were: anti-RYR1, 34C 
(dilution 1:30), Developmental Studies Hybridoma bank, University of Iowa; rabbit 
monoclonal anti-GR (dilution 1:100) from Abcam. Secondary antibodies were: Cy3-
labeled goat anti-rabbit IgG (dilution 1:300) for single GR labelling; Cy5-labeled goat 
anti-mouse IgG (dilution 1:200) and Cy3-labeled goat anti-rabbit IgG for double 
labelling (dilution 1:300).  Specimens were finally viewed using a scanning laser 
confocal microscope (LS510 META Carl Zeiss, Germany). 
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Immunogold labelling electron microscopy (EM). Soleus muscles were fixed for 
20 min at room temperature in a fixative mixture containing 2% paraformaldehyde 
and 0.5% glutaraldehyde (in PBS buffer). Smalls bundles were permeabilised and 
blocked as described above. After incubation with the rabbit monoclonal anti-GR 
from Abcam, secondary antibodies conjugated with Nanogold® particles were 
applied for 2h at 4°C (dilution 1:100).  Samples were then post-fixed with 1 % 
glutaraldehyde (in PBS buffer), at room temperature, and incubated with reagents to 
enhance the signal (Goldenhance™ EM Formulation - Nanoprobes, Yaphank NY 
11980-9710) for 5 minutes. Fibre bundles were finally embedded and sectioned 
using standard EM protocols (Boncompagni et al. 2009). Ultrathin sections of ~40 
nm were cut using a Leica Ultracut R microtome (Leica Microsystem, Austria) with a 
Diatome diamond knife (DiatomeLtd. CH-2501 Biel, Switzerland) and double-stained 
with uranyl acetate and lead citrate. Sections were viewed using a FP 505 Morgagni 
Series 268D electron microscope (FEI Company, Brno, Czech Republic), equipped 
with Megaview III digital camera and Soft Imaging System (Munster, Germany). 
As the monoclonal antibody used in the immunocytohistochemistry, 
immunofluorescence confocal microscopy and Immunogold labelling electron 
microscopy has never been tested before for use in these techniques, the findings 
were confirmed using a polyclonal rabbit anti-GR (Abcam ab35780) that is 
recommended for use in immunocytochemistry. 
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Statistical analysis 
As mentioned above, all the immunoblotting experiments were run in duplicate and 
each experiment was repeated at least twice. To determine the expression of the 
GCR in the various muscles, the Western blots were digitised and the intensity of the 
various protein bands were analysed using Scion Image® from NIH and normalised 
to that of the loading control (actin). Statistical analysis of the data was performed 
using SigmaPlot® 11.2 (Systat Software Inc., London, UK). The data obtained from 
each fibre type under control and from the various experimental conditions were 
compared using a two-way ANOVA with Tukey’s post hoc test and a P<0.05 was 
considered to be statistically significant. 
Results 
The results in Fig.1 show the expression and localisation of GRs in myoblasts (Fig. 
1A and 1B), myotubes (Fig. 1C and 1D) and adult muscle fibres (Fig. 1E and 1F). 
They confirm our previous findings in adult skeletal muscle fibres (Fig. 1E and 1F) 
but also show that the receptors were expressed throughout myogenesis and that 
their localisation, within the cell, changed with differentiation. Thus, they were 
localised in the cytoplasm in myoblasts (Fig 1A and 1B), in the nucleus in myotubes 
(Fig. 1C and 1D) and around the periphery of the muscle fibres, where they co-
localised with laminin, in adult skeletal muscle fibres (Fig. 1E and 1F). Moreover, this 
shift in the localisation of GRs was accompanied by an increase in the expression of 
laminin (green staining in Fig 1D and 1F). 
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To visualise the precise localisation of the receptors, in adult mammalian skeletal 
muscle fibres, a combination of immunofluorescence confocal microscopy (CM) and 
immunogold-labelling electron microscopy (EM) was used. Since we have previously 
shown that the GR is expressed mainly in oxidative fibres (Perez et al. 2013), the 
soleus muscle which contains mostly oxidative fibres (i.e. type I and IIA fibres) was 
used in this experiment. The immunofluorescence CM confirmed some of our 
previous findings. For example, it showed that most receptors were localised in 
clusters on the fibre surface where they generated a narrow, but discontinuous band 
around the fibres (Fig.2A; white dotted square). In addition, it provided new evidence 
showing that the receptors were also localised in large quantities in satellite cells 
(white arrow, Fig. 2B) and to a lesser extent inside the muscle fibres where they 
formed a striated pattern. The immunogold labelling confirmed the CM data (Fig. 2C, 
D and E), and clearly demonstrated that the GR was quite abundant in the 
extracellular matrix (Fig. 2C) and in satellite cells (Fig. 2E).  Gold particles were also 
found inside the fibres, preferentially but not exclusively, in the vicinity of 
mitochondria (Fig. 2F), that we know are specially localised at I bands (on both sides 
of Z lines) in adult fibres (Boncompagni et al. 2009). To determine the exact location 
of the GR signal inside the fibres, some of the fibres were double stained with an 
anti-GR and an antibody (anti-RYR1, 34C) that marks the position of Ca2+ release 
units (CRUs), or triads. In adult fibres, CRUs are specifically placed at the transition 
between A and I bands, where they form a very peculiar transverse double-cross 
striation on either side of the I band (Boncompagni et al., 2009a). They also contain 
the sarcoplasmic reticulum Ca2+ release channels, type-1 ryanodine receptors 
(RYR1). Double labelling for GRs and RYR1s (red and green, respectively in Fig. 
2G) indicated that the GR staining, inside the fibres was exclusively localised at the 
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I-band, flanked on either side by the two green lines marking the position of the 
triads. These findings also suggested that some of the gold particles that were not at 
the I band may have been nonspecific (Fig. 2C and 2D). As the I band region of adult 
fibres is rich in mitochondria (Boncompagni et al. 2009), the results in Fig. 2G agree 
with those in Fig. 2E-F showing gold particles in the proximity of mitochondria (the 
dark and branched organelles).    
To determine what tethers the GR in the extracellular matrix, laminin 2 (merosin, 
laminin 211) or integrins of the α7β1 type coupled to cyanogen bromide-activated 
sepharose beads were used to pull-down the GR from slow muscle lysates. As the 
results displayed in Fig. 3A show, only laminin coupled beads were able to bind and 
pull down the GR. Moreover, their ability to bind the receptor depended on the 
presence or absence of the ligand (GC). Thus, adding 500nM BDP to the muscle 
lysate, significantly reduced the amount of GR pulled down by the beads (Fig. 3B) 
suggesting that the GC was able to dissociate the GR from laminin. 
To determine the cellular signalling pathways activated by physiological 
concentrations of GCs in adult skeletal muscle, small muscle fibre bundles isolated 
from the extensor digitorum longus (edl, a fast-twitch muscle) and soleus (a slow-
twitch muscle) were treated with 250nM beclomethasone dipropionate (BDP, a 
synthetic GC widely used in the management of asthma). The phosphorylation 
(=activation) of JNK, ERK 1&2 and p38 MAPK was then determined. As the results 
displayed in Fig. 4 and Fig. 5 show, the effects of BDP on the phosphorylation of 
these kinases was complex and depended on the fibre type and the duration of the 
treatment. For example, treating the muscle fibre bundles with BDP for 5min 
increased the phosphorylation of p38 MAPK and ERK1&2 in the fast-twitch muscle 
fibres (Fig. 4A and C; Fig. 5A, D and E) and that of JNK in the slow-twitch fibres (Fig. 
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4B; Fig. 55B and C). Increasing the treatment time to 30min further enhanced the 
activation of p38MAPK in the fast-twitch fibres (Fig. 4A; Fig. 5A) and that of ERK 1&2 
(Fig. 4C; Fig. 5D and E). However, it led to the activation of JNK in both fibre types 
(see Fig.4B and C; Fig. 5B and C). In contrast, prolonging the treatment duration to 
60min led to a slight decrease in the phosphorylation of p38 MAPK and a marked 
decline in that of JNK in the fast-twitch fibres (Fig. 4A and 4B; Fig. 5A, B and C) but 
further enhanced that of JNK in the slow-twitch fibres (Fig. 4B; Fig. 5B and C). On 
the other hand, the phosphorylation of ERK 1&2 in the fast-twitch fibres remained 
elevated and was similar to that seen after the 30min treatment (Fig. 4C; Fig. 5D and 
E); whereas, in the slow-twitch fibres it was slightly reduced (Fig. 5D and E). 
The findings in Fig.4 and Fig. 5 suggested that the activation of MAPKs by GCs in 
mammalian skeletal muscles was non-genomic (i.e. it occurred within 5 minutes). 
However, they did not tell us the receptor/mechanism underlying this effect. As the 
mechanisms underlying the non-genomic effects of GCs are still controversial 
(Lipworth 2000; Stahn & Buttgereit 2008; Perez et al, 2013), we investigated whether 
the activation of the various MAPKs by BDP were mediated through the GR or 
through another receptor/mechanism. As the results displayed in Fig. 6A and 6B 
show, pre-treating the muscle fibre bundles with 10μM mifepristone (RU486, a GR 
inhibitor), for 10min, completely abolished or significantly reduced the 30min BDP-
induced activation of p38 MAPK and JNK suggesting that they were mediated by a 
GR. To determine whether they were mediated by a cGR or an mGR, the experiment 
above was repeated using the rabbit monoclonal anti-GR used in the 
immunocytochemistry and Western blotting experiment. The rationale behind this 
experiment was that the antibody was too large to cross the cell membrane and that 
it could only bind the GR and inhibit its effects, if the receptor was easily accessible 
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i.e. located close to the cell surface. As the results presented in Fig. 6C and 6D 
show, pre-treating the muscle fibre bundles with the antibody for 10min, completely 
abolished the BDP-induced activation of JNK and p38 MAPK in both fibre types 
suggesting that they were mediated by a GR that was easily accessible to the 
antibody (i.e. a cell surface GR). They also suggested that the antibody bound the 
GR close to the ligand binding site or caused a conformational change to the 
receptor that inhibited its activation of the MAPK pathway. 
The results presented so far suggested that the effects of BDP on the activation of 
the MAPK pathway were non-genomic and were mediated by a GR located close to 
the cell surface. They also suggested that it may be bound to laminin. However, they 
did not tell us how the GC was able to activate the MAPKs. In mammalian skeletal 
muscle fibres, laminin is localised in the basal laminar (one of the two layers that 
form the basement membrane of skeletal muscles) and is thought to communicate 
with the rest of the cell through integrins (mainly integrin α7β1 in skeletal muscle) 
and dystroglycan (Gawlik & Durbeej, 2011). This led us to hypothesise that the GR 
signalled to the MAPK through the activation of focal adhesion kinase (FAK) by 
integrins (see Fig.10). To test this hypothesis, we pre-treated another set of muscle 
fibre bundles with the FAK specific inhibitor, FAK inhibitor 14. As the results 
displayed in Fig. 7 and Fig. 8 show, pre-treatment of the fibre bundles with the 
inhibitor completely abolished the GC-induced activation of p38 MAPK (Fig. 7A; Fig. 
8A) and ERK 1 (p44; Fig. 7C; Fig. 8D and E). However, pre-treatment of the muscle 
bundles with the inhibitor alone augmented the activation of JNK (especially the 
46kDa isoform) in the slow twitch fibres and returned to the level observed in the 
BDP-treated fibres when the bundles were treated with both the inhibitor and the GC 
(Fig. 7B; Fig. 8B and C). 
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Discussion 
Localisation of the GR in mouse skeletal muscle cells 
The results we report here, show for the first time, that GRs are expressed at all 
stages of myogenesis. However, their localisation changes with differentiation 
(Fig.1).  They also revealed that, in adult mammalian skeletal muscle fibres, they 
were localised mostly in the extracellular matrix (Fig. 2A and C), in satellite cells (Fig. 
2B and 2D) and in the I band region where they were closely associated with 
mitochondria. Although a number of studies have previously suggested that a 
membrane glucocorticoid receptor exists in many cell types (Orchinik et al. 1991; 
Gametchu, 1993; Bartholome et al. 2004; Perez et al. 2013) this is the first study to 
show that a GR localised close to the cell membrane exists. However, as our results 
show, it is localised in the extracellular matrix and in satellite cells and not in the 
plasma membrane as  previous studies have suggested. 
Adult mammalian skeletal muscle fibres, unlike most other cell types, are long, 
cylindrical, multinucleated cells whose nuclei are located close to the fibre surface. 
Their cytoplasm (=sarcoplasm) is also packed with contractile proteins that are 
organised into striations consisting of highly regular repeats of thin (actin) and thick 
(myosin) filaments. Slow twitch fibres also contain large quantities of mitochondria 
that are mostly found at the I band region (Boncompagni et al. 2009) and under the 
sarcolemma (mostly in the proximity of capillaries). Here, we propose that this 
unique structural organisation of mammalian skeletal muscle fibres is responsible for 
the distinctive distribution and localisation of GRs in adult mammalian skeletal 
muscle fibres. We also hypothesis that, as myoblasts differentiate into myotubes, 
GRs migrate to the nucleus and as contractile proteins are laid down, the nucleus, 
the GRs and most other cell organelles are pushed to the periphery of the muscle 
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fibres. However, how the GRs get out of the muscle fibres and localises in the 
extracellular matrix is uncertain. Also, why and how the receptor localises in the 
proximity of mitochondria is also uncertain and further studies to investigate these 
uncertainties are necessary. 
Another possibility is that GRs are bound to or closely associated with cytoskeletal 
proteins such as dystrophins, dystroglycans, utrophins and laminins. In adult 
mammalian skeletal muscle fibres, these proteins are important in the maintenance 
of cell shape, structure and function and are closely associated with the cell 
membrane (Gawlik & Durbeej, 2011). Indeed, GCs have been shown to increase the 
content of dystrophin and utrophin in both normal and dystrophic differentiating 
human skeletal muscle satellite cells (Sklar et al, 1991; Pasquini et al, 1995). In the 
present study, GRs were also found to be able to bind laminin (Fig.3). The reason 
why GC treatment increases the accumulation of these proteins is uncertain. Here 
we postulate that, in mammalian skeletal muscles, GCs and hence GRs may be 
important for the synthesis, recruitment and/or organisation of these extracellular 
matrix proteins. Indeed, the present findings show that myoblasts expressed little or 
no laminin (Fig. 1A and 1B) and laminin only started to appear in myotubes when the 
GRs translocated into the nucleus (Fig. 1C and 1D). 
Effects of GCs on the MAPK pathway. 
Another novel finding in the present study is the observation that treating mammalian 
skeletal muscle fibre bundles with physiological concentrations of BDP increases the 
phosphorylation/activation of ERK 1&2, JNK and p38 MAPK in a fibre type- and 
duration-dependent manner (Figs 4 and 5). MAPKs are also activated in brain 
tissues of rats subjected to short periods of psychological stress (Gutierrez-Mecinas 
et al, 2011) as well as in hippocampal and PC12 (rat pheochrocytoma) cells treated 
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with low doses of corticosterone (Li et al, 2001; Qi et al, 2005). However, treatment 
of most other cell types, including HeLa cells, vascular endothelial cells, 
macrophages, mast cells and monocytes, with low doses of GCs has been shown to 
have the opposite effect i.e. it decreases MAPK activation (Franklin et al, 1997; 
Caelles et al, 1997; Gonzalez et al, 2000; Kassel et al, 2001; Imasato et al, 2002; 
Lasa et al, 2002; Bruna et al, 2003). Together these findings suggest that the effects 
of GCs on the MAPK pathway depend on the tissue that the cells are derived from 
and the physiological role of stress and MAPKs in that tissue. For example, in 
tissues such as the brain and skeletal muscle that are directly involved in the stress-
response and where activation of MAPKs by short term stress is beneficial 
(Gutierrez et al, 2011, Perez, et al, 2013; present study), physiological 
concentrations of GCs increase the activation of MAPKs. Conversely, in tissues such 
as the immune system where activation of MAPKs by stress is detrimental to the 
long term survival of the organism, GCs inhibit their activation (Franklin et al, 1997; 
Caelles et al, 1997; Gonzalez et al, 2000; Bruna et al, 2003). 
Physiological functions of GCs 
In mammalian skeletal muscle cells, all three MAPKs (p38 MAPK, JNK and ERK) 
have been implicated in the regulation of myogenesis and the expression of skeletal 
muscle specific genes (Bennett & Tonks, 1997; Cuenda et al, 1999; Weston et al, 
2003). Additionally, intense exercise (Widegren et al, 2000) and marathon running 
(Yu et al, 2001), both of which lead to fibre type switch, have been shown to induce 
the release of GCs and the activation of p38 and ERK 1&2 in the vastus lateralis 
portion of the quadriceps femoris muscle (note that the vastus lateralis consists 
mostly of fast-twitch muscle fibres). p38 MAPKs have also been shown to act as 
molecular switches in the activation of quiescent satellite cells (Jones et al, 2005). 
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Myogenesis is important in skeletal muscle development; whereas, satellite cell 
activation is essential for skeletal muscle repair/regeneration. The fact that GC 
treatment increases the activation of all three MAPKs in mouse skeletal muscle 
fibres (present study) and strenuous exercise activates p38 and ERK 1&2 in fast-
twitch fibres, suggests that GCs may play an important role in both myogenesis and 
skeletal muscle repair/regeneration.. However, the exact role of GCs in myogenesis 
and satellite cell activation is uncertain and further studies to confirm this are 
necessary. 
The GC-induced activation of ERK1&2 we report here may also be responsible for 
the GC-induced increase in maximum isometric force  (Po) in slow-twitch muscle 
fibres previously reported by Perez and her colleagues (Perez et al. 2013). Here we 
speculate that the GC-induced activation of ERK1&2 leads to the phosphorylation of 
the regulatory light chains of myosin (RMLCs) and the potentiation of Po as 
previously shown in Hamdi & Mutungi (2010) . Fast-twitch and slow-twitch muscle 
fibres express different isoforms of RMLCs that are phosphorylated at low 
stimulation frequencies in fast-twitch fibres and at high frequencies in slow-twitch 
fibres (Moor & Stull, 1984). The phosphorylation of RMLCs in fast-twitch fibres 
increases sub-maximal force (including twitch contraction); whereas, their function in 
slow-twitch muscles is unknown as their phosphorylation does not seem to affect 
twitch amplitude (Moore & Stull, 1984). Here we speculate that the phosphorylation 
of RMLCs in slow-twitch fibres leads to the potentiation maximum isometric force. 
However, the exact mechanism underlying the GC-induced increase in force is 
uncertain and further studies to confirm this are needed. 
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Mechanism underlying the effects of GCs in skeletal muscle 
As mentioned above, in most cells, GCs inhibit the MAPK pathway. They do this 
either by up-regulating the synthesis and activation of proteins such as 
glucocorticoid-induced-leucine zipper, MAPK phosphatase-1 and annexin-1 
(Gonzalez et al, 2000; Lasa et al, 2002) or by directly interacting with components of 
the MAPK pathway (Caelles et 1997; Bruna, 2003). The results reported here, 
suggest that the effects of GCs in mammalian skeletal muscle fibres are mediated 
through GRs localised close to the cell surface (Fig. 6) and that their stimulation 
leads to the activation of focal adhesion kinase (FAK, Fig. 9). Here we hypothesie 
that in mammalian skeletal muscle fibres, mGRs are bound to laminin and that their 
stimulation by GCs leads to a conformational change in laminin and the activation of 
FAK by integrins (Fig. 9). In mammalian skeletal muscles, laminin binds to and 
signals through both integrin α7β1 and dystroglycan (Gawlik & Durbeej, 2011). 
Therefore, we think that the conformational change in laminin activates integrin α7β1 
in fast-twitch muscle fibres and dystroglycan in slow-twitch fibres (Fig. 9).  We also 
think that integrins recruit and activate FAK leading eventually to the phosphorylation 
of p38 MAPK and ERK1&2; whereas, dystroglycans act slightly lower down the 
pathway and their stimulation leads to the activation of JNK. We also think that FAK 
has inhibitory effects on the dystroglycan pathway (Fig.9). However, the exact 
mechanism mediating the GC-induced increase in the activation of MAPKs in 
mammalian skeletal muscle fibres is uncertain and further studies to determine this 
are necessary. 
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